Physician profile
Michael Burke
NPI 1346229168
$1,161.16
in general payments reported to CMS, 2019-2025
11 companies · $25.20 in 2025
The $25.20 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $720 · 2022: $144 · 2023: $145 · 2024: $23.84 · 2025: $25.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $344.77 | 2021 | |
| Boston Scientific Corporation | $128.13 | 2023 | Spaceoar Vue System - 10ml |
| Coherus Oncology, INC. | $124.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2022 | |
| Eisai INC. | $121.35 | 2021 | |
| Jazz Pharmaceuticals INC. | $107.24 | 2021 | |
| Varian Medical Systems, INC. | $89.92 | 2019 | |
| Novocure INC. | $49.04 | 2024-2025 | Optune Gio, Optune |
| Glaxosmithkline, LLC. | $35.69 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Monteris Medical Corporation | $21.43 | 2021 | |
| Merck Sharp & Dohme LLC | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.